FUMAGALLI, ANDREA M.
 Distribuzione geografica
Continente #
NA - Nord America 119
AS - Asia 42
EU - Europa 40
SA - Sud America 8
Totale 209
Nazione #
US - Stati Uniti d'America 116
RU - Federazione Russa 14
SG - Singapore 14
CN - Cina 11
BR - Brasile 8
VN - Vietnam 8
IT - Italia 7
DE - Germania 6
BE - Belgio 3
GB - Regno Unito 3
PL - Polonia 3
HK - Hong Kong 2
IN - India 2
MX - Messico 2
BH - Bahrain 1
CA - Canada 1
CH - Svizzera 1
ES - Italia 1
FR - Francia 1
ID - Indonesia 1
KR - Corea 1
PH - Filippine 1
SE - Svezia 1
TR - Turchia 1
Totale 209
Città #
Fairfield 17
Ashburn 14
Ann Arbor 13
Chandler 9
Cambridge 8
Singapore 8
Woodbridge 7
Wilmington 6
Houston 5
Seattle 5
Brussels 3
Council Bluffs 3
Dearborn 3
Hanoi 3
Ho Chi Minh City 2
Hong Kong 2
Medford 2
Moscow 2
Nanjing 2
New York 2
San Jose 2
Shenyang 2
Zgierz 2
Altamura 1
Ankara 1
Balikpapan 1
Berlin 1
Boardman 1
Brasília 1
Brooklyn 1
Buffalo 1
Charlotte 1
Düsseldorf 1
Engenheiro Paulo de Frontin 1
Frankfurt am Main 1
General Trias 1
Gradisca D'isonzo 1
Guadalajara 1
Hartford 1
Hefei 1
Kumar 1
Lauterbourg 1
Lawrence 1
London 1
Los Angeles 1
Ludwigshafen am Rhein 1
Manama 1
Mexico City 1
Mirante da Serra 1
Mumbai 1
Ningbo 1
Nova Russas 1
Nuremberg 1
Palermo 1
Pamplona 1
Princeton 1
Salto 1
San Paolo di Civitate 1
Santa Clara 1
Santiago 1
Seoul 1
São Paulo 1
Tianjin 1
Uberlândia 1
Vancouver 1
Venice 1
Warsaw 1
Zibo 1
Totale 167
Nome #
Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies 213
Totale 213
Categoria #
all - tutte 724
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 724


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215 0 0 0 0 0 0 0 0 0 0 5 0
2021/202215 0 5 0 1 1 0 1 1 1 1 2 2
2022/202325 2 6 0 2 3 4 0 1 6 0 0 1
2023/20249 0 2 2 1 0 0 2 0 0 0 0 2
2024/202519 0 2 0 1 1 0 1 1 2 5 2 4
2025/202674 7 6 6 11 5 12 6 7 6 5 3 0
Totale 213